Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15003872rdf:typepubmed:Citationlld:pubmed
pubmed-article:15003872lifeskim:mentionsumls-concept:C1537056lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0024398lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C1622204lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0042196lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:15003872lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:15003872pubmed:issue1lld:pubmed
pubmed-article:15003872pubmed:dateCreated2004-3-8lld:pubmed
pubmed-article:15003872pubmed:abstractTextThe potential of vaccine-elicited anti-HIV envelope antibodies to control HIV-infection was evaluated by immunizing macaques with the HIV envelope protein and transiently depleting them of their CD8+ cells before intravenous challenge with the pathogenic CCR5-tropic SIV/HIV chimeric virus, SHIV(SF162P4). Although sterilizing immunity was not achieved, all vaccinated animals effectively controlled infection and remained free of disease for the duration of observation (over 3 years). In contrast, during the same period, the control animals progressed to disease. Both the vaccinees and the controls developed robust cell-mediated antiviral and neutralizing antibody responses following infection. A comparative analysis of these responses suggests that the more effective long-term control of infection by the vaccinated animals is due to the more rapid development of anti-HIV envelope antibodies. These studies suggest that priming by vaccination of B cell anti-HIV envelope responses maybe crucial for the long-term control of HIV infection.lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:languageenglld:pubmed
pubmed-article:15003872pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:citationSubsetIMlld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15003872pubmed:statusMEDLINElld:pubmed
pubmed-article:15003872pubmed:monthMarlld:pubmed
pubmed-article:15003872pubmed:issn0042-6822lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:BlanchardJame...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:GettieAgegneh...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:SafritJeffrey...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:BarnettSusan...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:StamatatosLeo...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:BucknerClaris...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:VojtechLuciaLlld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:SrivastavaInd...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:GinesLeoned...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:SaundersChery...lld:pubmed
pubmed-article:15003872pubmed:authorpubmed-author:BohmRudolphRlld:pubmed
pubmed-article:15003872pubmed:issnTypePrintlld:pubmed
pubmed-article:15003872pubmed:day1lld:pubmed
pubmed-article:15003872pubmed:volume320lld:pubmed
pubmed-article:15003872pubmed:ownerNLMlld:pubmed
pubmed-article:15003872pubmed:authorsCompleteYlld:pubmed
pubmed-article:15003872pubmed:pagination167-80lld:pubmed
pubmed-article:15003872pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:meshHeadingpubmed-meshheading:15003872...lld:pubmed
pubmed-article:15003872pubmed:year2004lld:pubmed
pubmed-article:15003872pubmed:articleTitlePriming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV.lld:pubmed
pubmed-article:15003872pubmed:affiliationAaron Diamond AIDS Research Center, The Rockefeller University, New York, NY 10016, USA.lld:pubmed
pubmed-article:15003872pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15003872pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:15003872pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15003872pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15003872lld:pubmed